Gene expression signatures associated with the resistance to imatinib.
about
Myosin Vb is required for trafficking of the cystic fibrosis transmembrane conductance regulator in Rab11a-specific apical recycling endosomes in polarized human airway epithelial cellsMisfolding, Aggregation, and Disordered Segments in c-Abl and p53 in Human Cancer.A genome-wide approach to identify genetic variants that contribute to etoposide-induced cytotoxicity.Ductular reaction correlates with fibrogenesis but does not contribute to liver regeneration in experimental fibrosis models.Reduced tumorigenicity and pathogenicity of cervical carcinoma SiHa cells selected for resistance to cidofovirGene expression signatures and response to imatinib mesylate in gastrointestinal stromal tumor.GSTT1 copy number gain and ZNF overexpression are predictors of poor response to imatinib in gastrointestinal stromal tumorsIdentification of genetic variants and gene expression relationships associated with pharmacogenes in humansTargeting survival cascades induced by activation of Ras/Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways for effective leukemia therapy.Chronic myeloid leukemia: an update of concepts and management recommendations of European LeukemiaNet.The gene expression profiles of medulloblastoma cell lines resistant to preactivated cyclophosphamide.Cobll1 is linked to drug resistance and blastic transformation in chronic myeloid leukemia.Gene expression signatures associated with the in vitro resistance to two tyrosine kinase inhibitors, nilotinib and imatinib.Nilotinib hampers the proliferation and function of CD8+ T lymphocytes through inhibition of T cell receptor signallingMicroRNA expression profiling in Imatinib-resistant Chronic Myeloid Leukemia patients without clinically significant ABL1-mutations
P2860
Q24304047-4E48B3C6-44F1-4D7B-9FB1-844C46BE6A29Q30374671-8D56F0E2-DE04-4CD2-B8C0-5D4C21A859D3Q30479559-85EF55BB-811B-485F-B861-726B557DD715Q33605760-99FD85EA-E784-48ED-BDBF-8255722578D1Q33643453-D4CB6CAB-F853-429A-86EA-E2B1E7AF8741Q33654894-A738B9A2-C244-427B-BF1E-43BC17CBEEC8Q35017113-00B69A49-BE7E-498E-A7E5-137703BC0460Q36935918-1FC19FA2-B42C-400E-B168-FFD6A22E6217Q37109225-144D5A29-9ADC-43A2-B4D1-ACDA938939ADQ37163550-ACC75F74-B71F-4EEA-8E5B-DD7593FFE73FQ38291073-0614C8FF-3EBF-4006-B1D1-B3DEF40A181CQ38715100-1DBC32AB-0F5F-4C3B-9151-1D69470140FFQ39308709-9A4A7BBC-9D79-43B3-BC9D-7BD53D0E8D43Q41963473-2000E993-447E-49B6-BC76-73AF9092577DQ42554932-34177D1E-2D08-4DF1-8CFE-7282B4AE9921
P2860
Gene expression signatures associated with the resistance to imatinib.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Gene expression signatures associated with the resistance to imatinib.
@en
Gene expression signatures associated with the resistance to imatinib.
@nl
type
label
Gene expression signatures associated with the resistance to imatinib.
@en
Gene expression signatures associated with the resistance to imatinib.
@nl
prefLabel
Gene expression signatures associated with the resistance to imatinib.
@en
Gene expression signatures associated with the resistance to imatinib.
@nl
P2093
P2860
P356
P1433
P1476
Gene expression signatures associated with the resistance to imatinib.
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.LEU.2404310
P577
2006-07-20T00:00:00Z